Matches in SemOpenAlex for { <https://semopenalex.org/work/W618181851> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W618181851 abstract "Ketoconazole has been shown in clinical trials to increase the plasma exposure of the oral anticoagulant prodrug AZD0837 [(2S)-N-{4- [(Z)-amino(methoxyimino)methyl]benzyl}-1-{(2R)-2-[3-chloro-5-(difluoromethoxy)phenyl]-2-hydroxyethanoyl}-azetidine-2-carboxamide] and its active metabolite, AR-H067637 [(2S)-N-{4-[amino(imino)methyl]benzyl}-1-{(2R)-2-[3-chloro-5-(difluoromethoxy)phenyl]-2-hydroxyethanoyl}-azetidine-2-carboxamide]. To investigate the biotransformation of AZD0837 and the effect of ketoconazole on this process, we used an experimental model in pigs that allows repeated sampling from three blood vessels, the bile duct, and a perfused intestinal segment. The pigs received AZD0837 (500 mg) given enterally either alone (n = 5) or together with single-dose ketoconazole (600 mg) (n = 6). The prodrug (n = 2) and its active metabolite (n = 2) were also administered intravenously to provide reference doses. The plasma data revealed considerable interindividual variation in the exposure of the prodrug, intermediate metabolite, and active metabolite. However, AR-H067637 was detected at very high concentrations in the bile with low variability (Ae(bile) = 53 ± 6% of the enteral dose), showing that the compound had indeed been formed in all of the animals and efficiently transported into the bile canaliculi. Concomitant dosing with ketoconazole increased the area under the plasma concentration-time curve for AZD0837 (by 99%) and for AR-H067637 (by 51%). The effect on the prodrug most likely arose from inhibited CYP3A-mediated metabolism. Reduced metabolism also seemed to explain the increased plasma exposure of the active compound because ketoconazole prolonged the terminal half-life with no apparent effect on the extensive biliary excretion and biliary clearance. These in vivo results were supported by in vitro depletion experiments for AR-H067637 in pig liver microsomes with and without the addition of ketoconazole." @default.
- W618181851 created "2016-06-24" @default.
- W618181851 creator A5041858887 @default.
- W618181851 date "2010-01-01" @default.
- W618181851 modified "2023-09-24" @default.
- W618181851 title "In vivo Pharmacokinetics of Two New Thrombin Inhibitor Prodrugs : Emphasis on Intestinal and Hepatobiliary Disposition and the Influence of Interacting Drugs" @default.
- W618181851 hasPublicationYear "2010" @default.
- W618181851 type Work @default.
- W618181851 sameAs 618181851 @default.
- W618181851 citedByCount "0" @default.
- W618181851 crossrefType "journal-article" @default.
- W618181851 hasAuthorship W618181851A5041858887 @default.
- W618181851 hasConcept C108215921 @default.
- W618181851 hasConcept C112705442 @default.
- W618181851 hasConcept C11824378 @default.
- W618181851 hasConcept C149151106 @default.
- W618181851 hasConcept C150903083 @default.
- W618181851 hasConcept C185592680 @default.
- W618181851 hasConcept C207001950 @default.
- W618181851 hasConcept C2777056448 @default.
- W618181851 hasConcept C2777477808 @default.
- W618181851 hasConcept C2779548794 @default.
- W618181851 hasConcept C2781064554 @default.
- W618181851 hasConcept C526171541 @default.
- W618181851 hasConcept C55493867 @default.
- W618181851 hasConcept C62231903 @default.
- W618181851 hasConcept C86803240 @default.
- W618181851 hasConcept C89423630 @default.
- W618181851 hasConcept C98274493 @default.
- W618181851 hasConceptScore W618181851C108215921 @default.
- W618181851 hasConceptScore W618181851C112705442 @default.
- W618181851 hasConceptScore W618181851C11824378 @default.
- W618181851 hasConceptScore W618181851C149151106 @default.
- W618181851 hasConceptScore W618181851C150903083 @default.
- W618181851 hasConceptScore W618181851C185592680 @default.
- W618181851 hasConceptScore W618181851C207001950 @default.
- W618181851 hasConceptScore W618181851C2777056448 @default.
- W618181851 hasConceptScore W618181851C2777477808 @default.
- W618181851 hasConceptScore W618181851C2779548794 @default.
- W618181851 hasConceptScore W618181851C2781064554 @default.
- W618181851 hasConceptScore W618181851C526171541 @default.
- W618181851 hasConceptScore W618181851C55493867 @default.
- W618181851 hasConceptScore W618181851C62231903 @default.
- W618181851 hasConceptScore W618181851C86803240 @default.
- W618181851 hasConceptScore W618181851C89423630 @default.
- W618181851 hasConceptScore W618181851C98274493 @default.
- W618181851 hasLocation W6181818511 @default.
- W618181851 hasOpenAccess W618181851 @default.
- W618181851 hasPrimaryLocation W6181818511 @default.
- W618181851 hasRelatedWork W1597211147 @default.
- W618181851 hasRelatedWork W1982903194 @default.
- W618181851 hasRelatedWork W1984261623 @default.
- W618181851 hasRelatedWork W1985581550 @default.
- W618181851 hasRelatedWork W1993455912 @default.
- W618181851 hasRelatedWork W2021959944 @default.
- W618181851 hasRelatedWork W2029293627 @default.
- W618181851 hasRelatedWork W2029903081 @default.
- W618181851 hasRelatedWork W2046030012 @default.
- W618181851 hasRelatedWork W2145763518 @default.
- W618181851 hasRelatedWork W2150776007 @default.
- W618181851 hasRelatedWork W2153577443 @default.
- W618181851 hasRelatedWork W2168790872 @default.
- W618181851 hasRelatedWork W2188526970 @default.
- W618181851 hasRelatedWork W2332299770 @default.
- W618181851 hasRelatedWork W2521548316 @default.
- W618181851 hasRelatedWork W2899568934 @default.
- W618181851 hasRelatedWork W3012478138 @default.
- W618181851 hasRelatedWork W3023377413 @default.
- W618181851 hasRelatedWork W601058385 @default.
- W618181851 isParatext "false" @default.
- W618181851 isRetracted "false" @default.
- W618181851 magId "618181851" @default.
- W618181851 workType "article" @default.